journal article·2019-03-13

Bioengineered Nanocage from HBc Protein for Combination Cancer Immunotherapy

Wenjun Shan, Haiping Zheng, Guofeng Fu, Chenfeng Liu, Zizhen Li, Yuhan Ye, Jie Zhao, Dan Xu, Liping Sun, Xin Wang, Xiao Lei Chen, Shengli Bi, Lei Ren, Guo Fu

Nano Letters· Volume 19· Issue 3
Publisher page

Abstract

Protein nanocages are promising multifunctional platforms for nanomedicine owing to the ability to decorate their surfaces with multiple functionalities through genetic and/or chemical modification to achieve desired properties for therapeutic and diagnostic purposes. Here, we describe a model antigen (OVA peptide) that was conjugated to the surface of a naturally occurring hepatitis B core protein nanocage (HBc NC) by genetic modification. The engineered OVA-HBc nanocages (OVA-HBc NCs), displaying high density repetitive array of epitopes in a limited space by self-assembling into symmetrical structure, not only can induce bone marrow derived dendritic cells (BMDC) maturation effectively but also can be enriched in the draining lymph nodes. Naïve C57BL/6 mice immunized with OVA-HBc NCs are able to generate significant and specific cytotoxic T lymphocyte (CTL) responses. Moreover, OVA-HBc NCs as a robust nanovaccine can trigger preventive antitumor immunity and significantly delay tumor growth. When combined with a low-dose chemotherapy drug (paclitaxel), OVA-HBc NCs could specifically inhibit progression of an established tumor. Our findings support HBc-based nanocages with modularity and scalability as an attractive nanoplatform for combination cancer immunotherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Monoclonal and Polyclonal Antibodies Research · vaccines and immunoinformatics approaches

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomaterials, Key Laboratory of Biomedical Engineering of Fujian Province, State Key Lab of Physical Chemistry of Solid Surface, College of Materials, Xiamen University, Xiamen, Fujian 361005, P. R. China

State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian 361102, China

National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, Fujian 361102, P. R. China

Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361005, P. R. China

Chinese Center for Disease Control & Prevention Institute for Viral Disease Control & Prevention, Beijing 102206, P. R. China

Cancer Research Center of Xiamen University, Xiamen, Fujian 361102, China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China

References (33)

Show source-provided references
1. 10.1038/s41467-018-05118-310.1038/s41467-018-05118-3 ↗
2. 10.1038/s41568-018-0061-010.1038/s41568-018-0061-0 ↗
3. 10.1038/nature1067310.1038/nature10673 ↗
4. 10.1038/nrclinonc.2018.2910.1038/nrclinonc.2018.29 ↗
5. 10.1038/nrc323910.1038/nrc3239 ↗
6. 10.4161/onci.2596210.4161/onci.25962 ↗
7. 10.1172/JCI4026910.1172/JCI40269 ↗
8. 10.1158/1078-0432.CCR-07-051710.1158/1078-0432.CCR-07-0517 ↗
9. 10.1158/2326-6066.CIR-15-006410.1158/2326-6066.CIR-15-0064 ↗
10. 10.1038/cmi.2017.15510.1038/cmi.2017.155 ↗
11. 10.1182/blood-2014-04-56793310.1182/blood-2014-04-567933 ↗
12. 10.1038/nature1442610.1038/nature14426 ↗
13. 10.1146/annurev-immunol-032414-11204910.1146/annurev-immunol-032414-112049 ↗
14. 10.1126/science.356.6334.12210.1126/science.356.6334.122 ↗
15. 10.1038/am.2016.12810.1038/am.2016.128 ↗
16. 10.1016/j.addr.2016.03.00210.1016/j.addr.2016.03.002 ↗
17. 10.1016/j.ymeth.2006.05.01610.1016/j.ymeth.2006.05.016 ↗
18. 10.1016/j.copbio.2007.10.01310.1016/j.copbio.2007.10.013 ↗
19. 10.1586/erv.10.11510.1586/erv.10.115 ↗
20. 10.1016/j.vaccine.2012.10.08310.1016/j.vaccine.2012.10.083 ↗
21. 10.1016/S0014-5793(98)01599-310.1016/S0014-5793(98)01599-3 ↗
22. 10.1084/jem.158.2.30310.1084/jem.158.2.303 ↗
23. 10.1016/j.it.2016.09.00610.1016/j.it.2016.09.006 ↗
24. 10.1038/s41467-018-04985-010.1038/s41467-018-04985-0 ↗
25. 10.1084/jem.192.12.168510.1084/jem.192.12.1685 ↗
26. 10.1111/febs.1376710.1111/febs.13767 ↗
27. 10.1016/j.vaccine.2014.03.07810.1016/j.vaccine.2014.03.078 ↗
28. 10.1371/journal.ppat.100661810.1371/journal.ppat.1006618 ↗
29. 10.1073/pnas.050372610210.1073/pnas.0503726102 ↗
30. 10.1038/ni88910.1038/ni889 ↗
31. 10.1021/acsnano.7b0097810.1021/acsnano.7b00978 ↗
32. 10.1021/mp060096p10.1021/mp060096p ↗
33. 10.1021/bc800338n10.1021/bc800338n ↗